Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-18

FDA Approved: ERYTHROMYCIN AND BENZOYL PEROXIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a generic topical combination product of erythromycin and benzoyl peroxide for acne under ANDA065385 by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERYTHROMYCIN AND BENZOYL PEROXIDE (erythromycin and benzoyl peroxide)

Snippet

ORIG AP for ERYTHROMYCIN AND BENZOYL PEROXIDE (ERYTHROMYCIN AND BENZOYL PEROXIDE)